Arvinas Inc (ARVN)
32.27
-0.55
(-1.68%)
USD |
NASDAQ |
May 06, 16:00
32.27
0.00 (0.00%)
After-Hours: 20:00
Arvinas Price to Book Value: 3.329 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.386 |
| May 02, 2024 | 3.345 |
| May 01, 2024 | 3.351 |
| April 30, 2024 | 3.277 |
| April 29, 2024 | 3.291 |
| April 26, 2024 | 3.339 |
| April 25, 2024 | 3.260 |
| April 24, 2024 | 3.357 |
| April 23, 2024 | 3.507 |
| April 22, 2024 | 3.600 |
| April 19, 2024 | 3.582 |
| April 18, 2024 | 3.537 |
| April 17, 2024 | 3.451 |
| April 16, 2024 | 3.450 |
| April 15, 2024 | 3.582 |
| April 12, 2024 | 3.744 |
| April 11, 2024 | 3.844 |
| April 10, 2024 | 3.789 |
| April 09, 2024 | 3.928 |
| April 08, 2024 | 3.884 |
| April 05, 2024 | 3.862 |
| April 04, 2024 | 3.910 |
| April 03, 2024 | 3.981 |
| April 02, 2024 | 4.027 |
| April 01, 2024 | 4.168 |
| Date | Value |
|---|---|
| March 28, 2024 | 4.258 |
| March 27, 2024 | 4.264 |
| March 26, 2024 | 4.230 |
| March 25, 2024 | 4.195 |
| March 22, 2024 | 4.322 |
| March 21, 2024 | 4.472 |
| March 20, 2024 | 4.555 |
| March 19, 2024 | 4.390 |
| March 18, 2024 | 4.394 |
| March 15, 2024 | 4.627 |
| March 14, 2024 | 4.613 |
| March 13, 2024 | 4.795 |
| March 12, 2024 | 4.692 |
| March 11, 2024 | 4.694 |
| March 08, 2024 | 4.852 |
| March 07, 2024 | 4.918 |
| March 06, 2024 | 4.744 |
| March 05, 2024 | 4.818 |
| March 04, 2024 | 4.794 |
| March 01, 2024 | 4.879 |
| February 29, 2024 | 4.743 |
| February 28, 2024 | 4.739 |
| February 27, 2024 | 4.953 |
| February 26, 2024 | 5.033 |
| February 23, 2024 | 4.848 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.707
Minimum
Oct 27 2023
19.38
Maximum
Dec 30 2020
5.226
Average
4.891
Median
Dec 06 2021
Price to Book Value Benchmarks
| Pfizer Inc | 1.792 |
| Bristol-Myers Squibb Co | 5.397 |
| Janux Therapeutics Inc | 9.330 |
| Geron Corp | 6.407 |
| Verastem Inc | 5.245 |
Price to Book Value Related Metrics
| PS Ratio | 22.82 |
| PEG Ratio | -0.2238 |
| Price | 32.27 |
| Earnings Yield | -20.14% |
| Market Cap | 2.197B |
| PEGY Ratio | -0.2238 |